RecruitingPhase IIEN originalKidney cancerMetastatic / advanced

CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The purpose of this study is to evaluate the safety and feasibility of a treatment holiday strategy directed by CD70-targeted immuno-PET/CT in patients with metastatic clear cell renal cell carcinoma (mccRCC). Specifically, the study aims to assess whether patients who achieve both anatomical disease control and metabolic response after 12 months of first-line PD-1/PD-L1 ICI + VEGFR-TKI combination therapy can safely pause their treatment, improve quality of life without compromising therapeutic efficacy.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Wiek 18 lat lub więcej
  • Zaawansowany rak nerki z przerzutami (stadium IV), który nie może być operacyjnie usunięty
  • Potwierdzone histologicznie lub cytologicznie zaawansowane nowotwory nerki, głównie typu jasnokomórkowego
  • Ocena ryzyka klinicznego pośrednia lub korzystna
  • Ogólny stan zdrowia pozwalający na aktywność (co najmniej 70% sprawności)
  • Co najmniej jedno widoczne ognisko nowotworu na tomografii
  • Prawidłowe wyniki badań krwi i funkcji narządów wewnętrznych
  • Podpisana świadoma zgoda na udział w badaniu

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
July 23, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (5)

Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University

Nanjing, China

Nanjing First Hospital, Nanjing Medical University

Nanjing, China

The First Affiliated Hospital of Nanjing Medical University

Nanjing, China

Sir Run Run Hospital, Nanjing Medical University

Nanjing, China

Wuxi No.2 People's Hospital (Jiangnan University Medical Center)

Wuxi, China

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/24/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.